Japan, June 10 -- CYTOMX THERAPEUTICS INC has got intellectual property rights for 'MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES, AND METHODS OF USING THE SAME.' Other related details are as follows:
Application Number: JP,2024-054350
Category (FI): C12N15/62,C07K16/30,A61P43/00,111,A61P37/02,A61P43/00,105,A61K39/395@N,C12N15/13,C12N15/63@Z,C12P21/08,C07K16/28,A61K45/00,C07K16/46
Stage: Grant (IP right granted following substantive examination.)
Filing Date: March 28, 2024
Publication Date: June 20, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....